z-logo
open-access-imgOpen Access
Changes in Deoxyribonucleic Acid Methylation Contribute to the Pathophysiology of Multiple Sclerosis
Author(s) -
Naiara Celarain,
J. TomàsRoig
Publication year - 2019
Publication title -
frontiers in genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.413
H-Index - 81
ISSN - 1664-8021
DOI - 10.3389/fgene.2019.01138
Subject(s) - epigenetics , dna methylation , multiple sclerosis , biology , disease , mechanism (biology) , gene , immune system , genetics , bioinformatics , neuroscience , immunology , gene expression , medicine , pathology , philosophy , epistemology
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by loss of coordination, weakness, dysfunctions in bladder capacity, bowel movement, and cognitive impairment. Thus, the disease leads to a significant socioeconomic burden. In the pathophysiology of the disease, both genetic and environmental risk factors are involved. Gene x environment interaction is modulated by epigenetic mechanisms. Epigenetics refers to a sophisticated system that regulates gene expression with no changes in the DNA sequence. The most studied epigenetic mechanism is the DNA methylation. In this review, we summarize the data available from the current literature by grouping sets of differentially methylated genes in distinct biological categories: the immune system including innate and adaptive response, the DNA damage, and the central nervous system.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom